Ben Greenfield Fitness: Diet, Fat Loss And Performance

Full Show Notes: https://bengreenfieldlife.com/noompodcast/ In this episode, Geoff Cook, CEO of Noom, talks about the science and practicalities of GLP-1 microdosing for weight loss and longevity. He breaks down what microdosing means, how Noom combines low-dose GLP-1 with behavior change programs to promote sustainable results, and the broader health benefits beyond just weight loss—such as improved metabolic markers and reduced inflammation. The conversation also covers safety, affordability, and Noom's new at-home blood testing for tracking progress. Geoff Cook is the CEO of Noom. He is also a serial entrepreneur and long-time public company CEO. He co-founded The Meet Group, a NASDAQ-listed social dating and live-streaming company connecting millions of active users globally. Geoff served as The Meet Group’s CEO from 2013 to 2023, leading it through its sale for $500 million in 2020. Noom Health partners with top health plans and employers to offer a suite of solutions, includin